Dolby Laboratories, Inc.DLBNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank62
3Y CAGR-14.6%
5Y CAGR-6.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-14.6%/yr
Quarterly compound
5Y CAGR
-6.3%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.39% |
| Q3 2025 | 2.25% |
| Q2 2025 | 6.93% |
| Q1 2025 | -7.40% |
| Q4 2024 | -2.91% |
| Q3 2024 | 4.79% |
| Q2 2024 | 4.81% |
| Q1 2024 | -6.77% |
| Q4 2023 | -4.82% |
| Q3 2023 | 2.52% |
| Q2 2023 | 1.10% |
| Q1 2023 | 5.43% |
| Q4 2022 | 3.83% |
| Q3 2022 | -1.26% |
| Q3 2022 | -6.77% |
| Q2 2022 | -2.04% |
| Q4 2021 | 11.07% |
| Q3 2021 | -0.21% |
| Q2 2021 | -5.64% |
| Q1 2021 | 3.19% |
| Q4 2020 | 3.31% |
| Q3 2020 | 3.60% |
| Q2 2020 | -0.84% |
| Q1 2020 | 4.23% |
| Q4 2019 | -4.22% |
| Q3 2019 | -0.36% |
| Q2 2019 | 3.04% |
| Q1 2019 | -0.04% |
| Q4 2018 | -3.06% |
| Q3 2018 | 0.24% |
| Q2 2018 | 1.45% |
| Q1 2018 | 5.40% |
| Q4 2017 | -2.38% |
| Q3 2017 | -3.03% |
| Q2 2017 | 2.21% |
| Q1 2017 | 1.43% |
| Q4 2016 | -2.86% |
| Q3 2016 | 7.71% |
| Q3 2016 | 5.55% |
| Q2 2016 | -2.33% |